Belgium (BE)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Experimental Observation of Strong Exciton Effects in Graphene Nanoribbons (2020) Tries A, Osella S, Zhang P, Xu F, Ramanan C, Klaeui M, Mai Y, et al. Journal article How do 66 European institutional review boards approve one protocol for an international prospective observational study on traumatic brain injury? Experiences from the CENTER-TBI study (2020) Timmers M, Van Dijck JTJM, Van Wijk RPJ, Legrand V, Van Veen E, Maas AIR, Menon DK, et al. Journal article Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies (2020) Lejeune M, Kose MC, Duray E, Einsele H, Beguin Y, Caers J Journal article, Review article Inter-protein interactions govern protein loading into porous vaterite CaCO3crystals (2020) Feoktistova NA, Balabushevich NG, Skirtach AG, Volodkin D, Vikulina AS Journal article Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study (2020) Sardanelli F, Trimboli RM, Houssami N, Gilbert FJ, Helbich TH, Alvarez Benito M, Balleyguier C, et al. Journal article Predictors of progression in systemic sclerosis patients with interstitial lung disease (2020) Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler J, et al. Journal article, Review article Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry (2020) Kaemmerer H, Gorenflo M, Huscher D, Pittrow D, Apitz C, Baumgartner H, Berger F, et al. Journal article Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib (RIB) plus fulvestrant (FUL) as first-line (1L) and second-line (2L) therapy in MONALEESA-3 (ML-3) (2020) Fasching P, Neven P, Jerusalem G, Beck JT, Chan A, De Laurentiis M, Bianchi GV, et al. Conference contribution Quality-adjusted survival with ribociclib plus fulvestrant (R plus F) versus placebo plus fulvestrant (P plus F) in postmenopausal women (PMW) HR+/HER2-advanced breast cancer (ABC) based on the MONALEESA-3 trial (2020) Jerusalem G, Delea T, Martin Jimenez M, De Laurentiis M, Nusch A, Beck JT, Chan A, et al. Conference contribution Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning (2020) Bokhorst JM, Blank A, Lugli A, Zlobec I, Dawson H, Vieth M, Rijstenberg LL, et al. Journal article